Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s11481-021-09982-7. Article type: Review Article Keywords: Multiple sclerosis, Experimental…
Abstract Background and Purpose: Cannabidiol (CBD) has been shown to differentially regulate the mechanistic target of rapamycin complex 1 (mTORC1)…
Abstract Many people with MS (pwMS) use unregulated cannabis or cannabis products to treat the symptoms associated with the disease.…
Abstract Paroxysmal symptoms are well-recognized manifestations of multiple sclerosis (MS). These are characterized by multiple, brief, sudden onset, and stereotyped…
Abstract Multiple sclerosis (MS) pathology progressively affects multiple central nervous system (CNS) areas. Due to this fact, MS produces a…
Abstract Background: For patients with chronic, non-cancer pain, traditional pain-relieving medications include opioids, which have shown benefits but are associated…
Abstract The consistency, efficacy, and safety of cannabis-based medicines have been demonstrated in humans, leading to the approval of the…
Abstract Dysfunctions in the endocannabinoid system have been associated with experimental animal models and multiple sclerosis patients. Interestingly, the endocannabinoid…
Abstract Objective: The objective of this study was to characterize the use of cannabis-based products (CBPs) by multiple sclerosis (MS)…
Abstract Multiple sclerosis (MS) is a chronic and disabling disorder of the central nervous system (CNS) characterized by neuroinflammation leading…